TW200516075A - 2-substituted pyrimidines - Google Patents

2-substituted pyrimidines

Info

Publication number
TW200516075A
TW200516075A TW093122163A TW93122163A TW200516075A TW 200516075 A TW200516075 A TW 200516075A TW 093122163 A TW093122163 A TW 093122163A TW 93122163 A TW93122163 A TW 93122163A TW 200516075 A TW200516075 A TW 200516075A
Authority
TW
Taiwan
Prior art keywords
substituted pyrimidines
compounds
description
pesticides
formulae
Prior art date
Application number
TW093122163A
Other languages
English (en)
Chinese (zh)
Inventor
Anja Schwoegler
Markus Gewehr
Bernd Mueller
Thomas Grote
Wassilios Grammenos
Jordi Tormo I Blasco
Andreas Gypser
Joachim Rheinheimer
Carsten Blettner
Peter Schaefer
Frank Schieweck
Oliver Wagner
Reinhard Stierl
Ulrich Schoefl
Siegfried Strathmann
Maria Scherer
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of TW200516075A publication Critical patent/TW200516075A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW093122163A 2003-07-24 2004-07-23 2-substituted pyrimidines TW200516075A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09

Publications (1)

Publication Number Publication Date
TW200516075A true TW200516075A (en) 2005-05-16

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093122163A TW200516075A (en) 2003-07-24 2004-07-23 2-substituted pyrimidines

Country Status (30)

Country Link
US (1) US7375108B2 (https=)
EP (1) EP1651618B1 (https=)
JP (1) JP2006528603A (https=)
KR (1) KR20060052857A (https=)
AP (1) AP2157A (https=)
AR (1) AR045100A1 (https=)
AT (1) ATE350370T1 (https=)
AU (1) AU2004261373B8 (https=)
BR (1) BRPI0412891A (https=)
CA (1) CA2532718A1 (https=)
CO (1) CO5660292A2 (https=)
CR (1) CR8184A (https=)
CY (1) CY1106391T1 (https=)
DE (1) DE502004002570D1 (https=)
DK (1) DK1651618T3 (https=)
EA (1) EA010566B1 (https=)
EC (1) ECSP066278A (https=)
ES (1) ES2279395T3 (https=)
HR (1) HRP20070057T3 (https=)
IL (1) IL172848A0 (https=)
MA (1) MA27949A1 (https=)
MX (1) MXPA06000038A (https=)
NZ (1) NZ545103A (https=)
PE (1) PE20050882A1 (https=)
PL (1) PL1651618T3 (https=)
PT (1) PT1651618E (https=)
SI (1) SI1651618T1 (https=)
TW (1) TW200516075A (https=)
UY (1) UY28436A1 (https=)
WO (1) WO2005012261A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005571A1 (de) * 2004-07-14 2006-01-19 Basf Aktiengesellschaft 2-substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
NZ610225A (en) * 2010-11-16 2015-08-28 Acetylon Pharmaceuticals Inc Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
WO2015054099A1 (en) 2013-10-08 2015-04-16 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors
US9278963B2 (en) 2013-10-10 2016-03-08 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
US10660890B2 (en) 2013-10-24 2020-05-26 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) Treatment of polycystic diseases with an HDAC6 inhibitor
WO2015084905A1 (en) 2013-12-03 2015-06-11 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and immunomodulatory drugs
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
JP6952602B2 (ja) 2014-07-07 2021-10-20 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. ヒストンデアセチラーゼ阻害剤による白血病の治療
US9937174B2 (en) 2014-12-05 2018-04-10 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
US11813261B2 (en) 2016-04-19 2023-11-14 Acetylon Pharmaceuticals, Inc. HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemia
JP6976577B2 (ja) * 2016-07-20 2021-12-08 国立大学法人東北大学 PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503542A (ja) 2000-06-13 2004-02-05 ビーエーエスエフ アクチェンゲゼルシャフト 殺真菌性5−フェニル置換2−(シアノアミノ)ピリミジン誘導体
EA007719B1 (ru) * 2001-03-15 2006-12-29 Басф Акциенгезельшафт 5-фенилпиримидины, способ и промежуточные продукты для их получения и их применение для борьбы с фитопатогенными грибами
NZ533265A (en) * 2001-11-19 2006-05-26 Basf Ag 5-Phenylpyrimidines, their preparation, compositions comprising them and their use

Also Published As

Publication number Publication date
CA2532718A1 (en) 2005-02-10
HRP20070057T3 (hr) 2007-07-31
SI1651618T1 (sl) 2007-06-30
EP1651618B1 (de) 2007-01-03
PT1651618E (pt) 2007-03-30
UY28436A1 (es) 2005-02-28
AP2157A (en) 2010-09-13
US20070105873A1 (en) 2007-05-10
ATE350370T1 (de) 2007-01-15
EA010566B1 (ru) 2008-10-30
KR20060052857A (ko) 2006-05-19
US7375108B2 (en) 2008-05-20
JP2006528603A (ja) 2006-12-21
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
MA27949A1 (fr) 2006-06-01
AP2006003497A0 (en) 2006-02-28
PE20050882A1 (es) 2005-12-01
EP1651618A1 (de) 2006-05-03
ES2279395T3 (es) 2007-08-16
ECSP066278A (es) 2006-07-28
IL172848A0 (en) 2006-06-11
DE502004002570D1 (de) 2007-02-15
AU2004261373B2 (en) 2010-08-19
MXPA06000038A (es) 2006-03-21
NZ545103A (en) 2008-06-30
BRPI0412891A (pt) 2006-10-03
WO2005012261A1 (de) 2005-02-10
AU2004261373A1 (en) 2005-02-10
CO5660292A2 (es) 2006-07-31
CY1106391T1 (el) 2011-10-12
CR8184A (es) 2006-10-06
AR045100A1 (es) 2005-10-12
PL1651618T3 (pl) 2007-05-31
AU2004261373B8 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
TW200617009A (en) Organic compounds
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
MX2007005933A (es) Compuestos de acetamida como fungicidas.
HRP20080664A2 (hr) Supstituirani piridinski herbicidi
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
SG151250A1 (en) Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors
MXPA02011370A (es) Iminoazinas substituidas.
TW200616541A (en) Benzoyl-substituted serineamides
MX2007005932A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.
TNSN06405A1 (en) Quinazolinone derivatives useful as vanilloid antagonistes
CY1106391T1 (el) 2-υποκατεστημενες πυριμιδινες
TW200635921A (en) Organic compounds
DE602004024213D1 (en) Aminopropanolderivate
SE0303541D0 (sv) New compounds
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
DE602006009789D1 (de) Acetylenderivate
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
MXPA05010651A (es) Compuestos de pirazol.
TW200613251A (en) Organic compounds
ZA200700739B (en) 5-lodotetrazoles
MXPA05010650A (es) Pirazoles sustituidos.
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
IL178360A0 (en) 2-substituted pyrimidines and their use as pesticides
MXPA05011549A (es) Pirimidinas 2 - sustituidas.
TW200613277A (en) 2-substituted pyrimidines, processes for their preparation and their use for controlling harmful fungi